Trial site
Ronald Reagan UCLA Medical Center
- 28running trials
- 21closed trials
The trials here
What the 49 trials at this site are about, from their registry records.
- Conditions
- Stroke11 trials
- Acute myeloid leukaemia5 trials
- High blood pressure5 trials
- Pulmonary arterial hypertension5 trials
- Head and neck cancer4 trials
- Lung cancer4 trials
- Pancreatic cancer4 trials
- Prostate cancer4 trials
- Coronary artery disease3 trials
- Deep vein thrombosis and pulmonary embolism3 trials
- Gastric and oesophageal cancer3 trials
- Myelodysplastic syndromes3 trials
- and 23 more
- Phase
- Phase 314 trials
- Phase 17 trials
- Phase 43 trials
- Phase 2/32 trials
- Phase 21 trial
- Status
- Completed14 trials
- Recruiting14 trials
- Active, not recruiting11 trials
- Withdrawn4 trials
- Enrolling by invitation3 trials
- Terminated3 trials
- Lead sponsor
- University of California, Los Angeles11 trials
- Pfizer5 trials
- Abbott Medical Devices3 trials
- Seagen, a wholly owned subsidiary of Pfizer3 trials
- Boston Scientific Corporation2 trials
- and 19 more
Running trials
Recruiting
Minimally Invasive Neuroendoscopic Ultra-Early Targeted ICH Evacuation
Recruiting
Recruiting
Recruiting
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Recruiting
Study of Anitocabtagene Autoleucel in Participants With Non-Oncology Plasma Cell-Related Diseases
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Pain Injection Versus Epidural Anesthesia for Hip Surgery in Pediatric Patients With Cerebral Palsy
Recruiting
Active, not recruiting
Active, not recruiting
Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial
Recruiting
Enrolling by invitation
Active, not recruiting
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
Recruiting
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Active, not recruiting
Enrolling by invitation
Active, not recruiting
Enrolling by invitation
Pilot Study to Evaluate the Role of EBUS in the Diagnosis of Acute PE in Critically Ill Patients
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Stroke5 recruiting
- Bladder cancer2 recruiting
- Gastric and oesophageal cancer2 recruiting
- Head and neck cancer2 recruiting
- Lung cancer2 recruiting
- Myasthenia gravis2 recruiting
- Pancreatic cancer2 recruiting
- Prostate cancer2 recruiting
- Atrial fibrillation1 recruiting
- Cerebral palsy1 recruiting
- Cervical cancer1 recruiting
- Coronary artery disease1 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- High blood pressure1 recruiting
- Ovarian cancer1 recruiting
- Pulmonary arterial hypertension1 recruiting
Closed trials
Withdrawn
Withdrawn
Non-Invasive Measurement of Cardiac Output and Stroke Volume in PE
Completed
Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)
Terminated
Completed
Completed
Withdrawn
Non-Invasive Measurement of Cardiac Output and Stroke Volume in PAH/CTEPH
Completed
Completed
Recruiting
Completed
Applying Best Clinical Practices to Patients at High Risk of Respiratory Complications
Terminated
Terminated
Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.
Completed
Completed
Completed
Completed
FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT Study
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026